Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-16-2026-01_58_09-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Regulatory
  • AZ, Amgen will pilot FDA’s real-time clinical trial plan
  • Regulatory

AZ, Amgen will pilot FDA’s real-time clinical trial plan

Pharmaphorum

The FDA has published a plan to allow data from clinical trials to be reported to the agency as they occur in real time.

Read full story

pharminent April 29, 2026 (Last updated: April 29, 2026)

Pharmaphorum

The FDA has published a plan to allow data from clinical trials to be reported to the agency as they occur in real time.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: AstraZeneca faces uphill battle at upcoming adcomm in face of FDA questions
Next: Pfizer settles with generic drugmakers to protect blockbuster drug until 2031

Related Stories

  • Regulatory

Moderna flu vaccine wins unanimous support from FDA panel

pharminent June 18, 2026
  • Regulatory

MSD takes on Pfizer’s Prevnar with new Capvaxive approval

pharminent June 18, 2026
  • Regulatory

GSK claims FDA okay for first oral carbapenem antibiotic

pharminent June 18, 2026

You May Have Missed

  • News

pharminent June 19, 2026
wp_daily_digest_2026-06-19
  • News

pharminent June 19, 2026
  • M&A / Deals

Biogen to acquire RayThera for up to $1bn

pharminent June 19, 2026
  • News

pharminent June 18, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.